Xu C, Huang KK, Law JH, Chua JS, et al. Comprehensive molecular phenotyping of ARID1A-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities. Gut 2023 Mar 14:gutjnl-2022-328332. doi: 10.1136/gutjnl-2022-328332.
PMID: 36918265